Partnership website: https://www.eitmanufacturing.eu/
The manufacturing industry is a global base for prosperity and key to Europe’s economic, social and environmental sustainability. The sector is a main driver of industrial innovation, job creation and growth.
EIT Manufacturing brings together a growing network of top-tier industrial partners, leading academic and research institutions from across the region and innovative startups, scaleups and SMEs.
A key way of transforming knowledge into value is by overcoming the fragmented nature of many innovation networks. In order to ensure that innovations reach the market, industry has the right talent and entrepreneurs can thrive; EIT Manufacturing connects and integrates the areas of education, innovation and business creation.
Ultimately, EIT Manufacturing strives to accelerate faster innovation with the potential to improve everyday life globally, help meet Europe’s ambitious climate goals, and ensure that its workforce is ready for tomorrow’s challenges.
This innovation community will bring together all actors in this innovation ecosystem and should lead to innovative products, services and also processes.
There are 6 general objectives
These objectives are reflected in five different schemes for which organizations, researchers and industry (knowledge triangle) can apply:
The EIT publishes regularly calls for proposals for these different programmes. You can find out the opportunities and latest news at the webpage of the innovation community https://www.eitmanufacturing.eu/ or https://eit.europa.eu/our-communities/eit-manufacturing
The headquarter of this innovation community is in Paris but there are several regional hubs. There is no office in Belgium and Flemish interested parties need to contact the Darmstadt hub by mail central@eitmanufacturing.eu
You can also attend or watch InnoveEIT, the annual conference of the EIT where you can meet other members of the communities and experts of the EIT itself.
Finally you can contact the NCP for manufacturing, mark.antonissen@vlaio.be
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.